TCM
TNGX icon

Tenor Capital Management’s Tango Therapeutics TNGX Stock Holding History

Tenor Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-78,664
Closed -$895K – 786
2021
Q2 		$895K Sell
78,664
-42,836
-35% -$481K 0.02% 399
2021
Q1 		$1.35M Sell
121,500
-28,500
-19% -$328K 0.03% 321
2020
Q4 		$1.72M Hold
150,000
– – 0.05% 200
2020
Q3 		$1.55M Buy
+150,000
New +$1.53M 0.06% 180

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Tenor Capital Management's TNGX Position: Q3 2021 in Review

Tenor Capital Management sold out of Tango Therapeutics (TNGX) in Q3 2021, closing a stake of 78,664 shares — an estimated $895K sold.

Tenor Capital Management first reported a position in TNGX in Q3 2020 and held it in 4 quarters. The position peaked at $1.72M in Q4 2020. 46 funds tracked by Wall St. Rank hold TNGX as of Q3 2021.

  • Tenor Capital Management reported no remaining Tango Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Tenor Capital Management sold 78,664 Tango Therapeutics shares in Q3 2021, an estimated $895K.
  • Tenor Capital Management first reported a position in Tango Therapeutics in Q3 2020 and held it in 4 quarters.
  • Tenor Capital Management's Tango Therapeutics position peaked at $1.72M in Q4 2020.
  • 46 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2021.

Based on Tenor Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.